Trump administration launches TrumpRx website for discounted drugs

Audio By Carbonatix

NEW YORK (AP) — The Trump administration on Thursday launched TrumpRx, a website it says will help patients buy prescription drugs directly at a discounted rate at a time when health care and the cost of living are growing concerns for Americans.

“You’re going to save a fortune,” President Donald Trump said at the site’s unveiling. “And this is also so good for overall health care.”

The government-hosted website is not a platform for buying medications. Instead, it's set up as a facilitator, pointing Americans to drugmakers’ direct-to-consumer websites, where they can make purchases. It also provides coupons to use at pharmacies. The site launches with over 40 medications, including weight-loss drugs such as Ozempic and Wegovy.

The site is part of a larger effort by the Trump administration to show it's tackling the challenges of high costs. Affordability has emerged as a political vulnerability for Trump and his Republican allies going into November's midterm elections, as Americans remain worried about the cost of housing, groceries, utilities and other staples of middle-class identity.

Trump stressed that the lower prices were made possible by his pressuring of pharmaceutical companies on prices, saying he demanded that they charge the same costs in the U.S. as in other nations. He said prescription drug costs will increase in foreign countries as a result.

“We're tired of subsidizing the world,” Trump said at the evening event on the White House campus that lasted roughly 20 minutes.

The administration is touting substantial discounts, though it's unclear just how much impact the changes will have for family budgets. The site includes the disclaimer that prices “may be even lower” for people with insurance, as it lists the “out-of-pocket price.” Also, some consumers might be able to use available generics that cost less than brand-name medications.

Still, Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, hyped the website as being transformative. He said the lower prices for Ozempic and Wegovy would cause the country to collectively lose 100 million pounds this year. He suggested that lower prices for the fertility drug Gonal-F would trigger pregnancies nationwide.

“We’re going to have a lot of Trump babies with these costs,” Oz said.

The president first teased TrumpRx in September while announcing the first of his more than 15 deals with pharmaceutical companies to lower drug prices to match the lowest price offered in other developed nations. He said in December the website would provide “massive discounts to all consumers" — though it's unclear whether the prices available on drugmakers' websites will routinely be any lower than what many consumers could get through their insurance coverage.

The website's Thursday release came after it faced multiple delays, for reasons the administration hasn't publicly shared. Last fall, Oz told Trump the site would share prices for consumers before the end of the year. An expected launch in late January was also pushed back.

The president has spent the past several months seeking to spotlight his efforts to lower drug prices for Americans. He’s done that through deals with major pharmaceutical companies, including some of the biggest drugmakers like Pfizer, Eli Lilly and Merck, which have agreed to lower prices of their Medicaid drugs to so-called “most favored nations” pricing. As part of the deals, many of the companies' new drugs are also to be launched at discounted rates for consumer markets through TrumpRx.

Many of the details of Trump's deals with manufacturers remain unclear, and drug prices for patients in the U.S. can depend on many factors, including the competition a treatment faces and insurance coverage. Most people have coverage through work, the individual insurance market or government programs like Medicaid and Medicare, which shield them from much of the cost.

Trump’s administration also has negotiated lower prices for several prescription drugs for Medicare enrollees, through a direct negotiation program created by a 2022 law.